Company / Operating Cash Flow per Share
EXACT SCIENCES CORP Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$2.65
FY2025
5-year range
-$1.27 / $2.65
FY2021-FY2025
Trend
+128.1%
vs FY2024
Sector context
#76 of 155
Health Care
What the data says
At $2.65, EXACT SCIENCES CORP's operating cash flow per share ranks #76 of 155 in the Health Care sector. Operating Cash Flow per Share has increased for 3 consecutive years, from $-1.27 in FY2022 to $2.65 in FY2025.
Based on SEC 10-K filings.
2.65 in FY2025 with a 5-year CAGR of +23.4%.
Improved from $0.88 to $2.65 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +23.4%
- 10-Year CAGR
- -
Sector benchmark
#76 of 155 in Health CareTop 49% of 155This company $2.65 Sector average $6.77
▼
-60.9% below sector average
Key checks
Key Insights
- EXACT SCIENCES CORP's operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 128.1% year-over-year.
- Ranks #76 out of 155 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.65 | +128.1% |
| FY2024 | $1.16 | +32.3% |
| FY2023 | $0.88 | +169.2% |
| FY2022 | -$1.27 | -115.4% |
| FY2021 | -$0.59 | -163.7% |
| FY2020 | $0.92 | +202.0% |
| FY2019 | -$0.91 | -58.4% |
| FY2018 | -$0.57 | +12.1% |
| FY2017 | -$0.65 | +51.6% |
| FY2016 | -$1.35 | +11.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026